Commentator: Shin Chung-chul, Director of Health Center, Ji-Pu Industrial Trend Research Institute

International authoritative medical journal Lancet confirmed that obesity and diabetes significantly accelerate the development of metabolic steatohepatitis, metabolic steatohepatitis disease is one of the most common liver diseases in the world, is estimated to affect the world's population of about 25%, the serious threat of cirrhosis, or even liver cancer or liver failure. Taiwan's new national disease "Fatty Liver Disease" also pulls the alarm! Taiwan's 3 million health check data revealed the warning signs of fatty liver among the Chinese people, obesity rate surged past 70%, fatty liver is getting younger, according to statistics, in the past, there were about 3~4 people with fatty liver among every 10 people in the country, but now there is 1 person with fatty liver among every 2 people. With the introduction of new drugs, the treatment of metabolic fatty liver disease from the past indirect drug improvement into the era of drug therapy.